E-course: Management of metastatic kidney cancer
This e-course will show the latest indications for the medical treatment of metastatic renal cell carcinoma (RCC) according to the evidence showed in literature and at the ASCO GU 2023 congress.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 60 minutes |
Lectures will highlight the first-line and second-line treatment in this stage of the disease. The last part of the e-course will focus on the clinical management of adverse events following systemic treatment in metastatic RCC.
Speaker(s):
- Dr. L. Antonuzzo (IT)
- Prof. A. Volpe (IT)
Acknowledgment
This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.